Corey Hebert
Pediatrics · Gretna, LANPI 1457368037
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Emmaus Medical, Inc. at 43.9% of the total. Reporting peaked in 2022 at $424,823 and has fallen 68.9% since, to $132,207 in 2025. Among pediatrics clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 874 payments — averaging $1474.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Emmaus Medical, Inc.$566K
- GSK$520K
- Supernus Pharmaceuticals, Inc.$101K
- Collegium Pharmaceutical, Inc.$41K
- Ironshore Pharmaceuticals Inc.$30K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$15K
- plus $17K from 7 others
Across 754 payments — averaging $7772.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$3.7M
- Modernatx, Inc.$1.6M
- Sanofi Pasteur Inc.$413K
- Pfizer$29K
- Boehringer Ingelheim Canada Ltd.ltee$27K
- Biohaven Pharmaceutical Holding Company Ltd.$21K
- plus $15K from 1 others
What the payments were for
- Consulting fees$601,33047%
- Speaking & faculty fees$528,03041%
- Travel & lodging$143,26511%
- Food & beverage$16,1181%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Emmaus Medical, Inc. | 40 | $565,812 |
| GSK | 543 | $519,608 |
| Supernus Pharmaceuticals, Inc. | 159 | $100,512 |
| Collegium Pharmaceutical, Inc. | 40 | $40,525 |
| Ironshore Pharmaceuticals Inc. | 46 | $29,839 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 12 | $15,001 |
| Duchesnay USA Incorporated | 9 | $10,318 |
| Otsuka America Pharmaceutical, Inc. | 9 | $6,663 |
| Pfizer | 10 | $226 |
| Revance Therapeutics, Inc. | 2 | $156 |
| Corium, LLC | 2 | $41 |
| AbbVie | 1 | $25 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,288,742 in reported general payments places this provider in the 95th percentile of 913 pediatrics providers in Louisiana.
Other pediatrics in Gretna
- Katie QueenBogalusa$61K
- Elizabeth WhiteCovington$19K
- Neslihan GungorShreveport$16K
- Amy VitteLafayette$10K
- Alicia NicklasLafayette$9K
- Paul YuratichNew Orleans$9K
- Catherine SpillerWalker$8K
- Mamatha MandavaShreveport$8K
- Caroline KlineBaton Rouge$8K
- Sherri CaseyCovington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.